Commentary: absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C. [electronic resource]
Producer: 20140220Description: 553-4 p. digitalISSN:- 1365-2036
No physical items for this record
Publication Type: Journal Article; Comment
There are no comments on this title.
Log in to your account to post a comment.